Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure:: Role of changes in thymic output and T cell death

被引:63
作者
Lecossier, D
Bouchonnet, F
Schneider, P
Clavel, F
Hance, AJ
机构
[1] Hop Bichat Claude Bernard, INSERM, U552, IMEA, F-75018 Paris, France
[2] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
关键词
D O I
10.1086/319285
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Some patients infected with human immunodeficiency virus (HIV) who are experiencing antiretroviral treatment failure have persistent improvement in CD4(+) T cell counts despite high plasma viremia. To explore the mechanisms responsible for this phenomenon, 2 parameters influencing the dynamics of CD4(+) T cells were evaluated: death of mature CD4(+) T cells and replenishment of the CD4(+) T cell pool by the thymus. The improvement in CD4(+) T cells observed in patients with treatment failure was not correlated with spontaneous, Fas ligand-induced, or activation-induced T cell death. In contrast, a significant correlation between the improvement in CD4(+) T cell counts and thymic output, as assessed by measurement of T cell receptor excision circles, was observed. These observations suggest that increased thymic output contributes to the dissociation between CD4(+) T cell counts and viremia in patients failing antiretroviral therapy and support a model in which drug-resistant HIV strains may have reduced replication rates and pathogenicity in the thymus.
引用
收藏
页码:1009 / 1016
页数:8
相关论文
共 41 条
[1]  
AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
[2]   HIV INDUCES THYMUS DEPLETION INVIVO [J].
BONYHADI, ML ;
RABIN, L ;
SALIMI, S ;
BROWN, DA ;
KOSEK, J ;
MCCUNE, JM ;
KANESHIMA, H .
NATURE, 1993, 363 (6431) :728-732
[3]  
Chêne L, 1999, J VIROL, V73, P2064
[4]  
Chêne L, 1999, J VIROL, V73, P7533
[5]   T cell dynamics in HIV-1 infection [J].
Clark, DR ;
De Boer, RJ ;
Wolthers, KC ;
Miedema, F .
ADVANCES IN IMMUNOLOGY, VOL 73, 1999, 73 :301-327
[6]   Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors [J].
Croteau, G ;
Doyon, L ;
Thibeault, D ;
McKercher, G ;
Pilote, L ;
Lamarre, D .
JOURNAL OF VIROLOGY, 1997, 71 (02) :1089-1096
[7]  
DEEKS SG, 2000, 7 C RETR OPP INF 30, P120
[8]   Changes in thymic function with age and during the treatment of HIV infection [J].
Douek, DC ;
McFarland, RD ;
Keiser, PH ;
Gage, EA ;
Massey, JM ;
Haynes, BF ;
Polis, MA ;
Haase, AT ;
Feinberg, MB ;
Sullivan, JL ;
Jamieson, BD ;
Zack, JA ;
Picker, LJ ;
Koup, RA .
NATURE, 1998, 396 (6712) :690-695
[9]   T-HELPER TYPE 1/T HELPER TYPE-2 CYTOKINES AND T-CELL DEATH - PREVENTIVE EFFECT OF INTERLEUKIN-12 ON ACTIVATION-INDUCED AND CD95 (FAS/APO-1)-MEDIATED APOPTOSIS OF CD4(+) T-CELLS FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS [J].
ESTAQUIER, J ;
IDZIOREK, T ;
ZOU, WP ;
EMILIE, D ;
FARBER, CM ;
BOUREZ, JM ;
AMEISEN, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1759-1767
[10]  
FRY TJ, 2000, 7 C RETR OPP INF SAN, P235